Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 2
1974 2
1980 1
1981 3
1982 1
1983 2
1984 7
1985 12
1986 7
1987 13
1988 6
1989 8
1990 3
1991 11
1992 6
1993 22
1994 15
1995 24
1996 21
1997 24
1998 29
1999 18
2000 34
2001 29
2002 36
2003 20
2004 22
2005 25
2006 36
2007 34
2008 23
2009 21
2010 21
2011 23
2012 23
2013 38
2014 17
2015 31
2016 24
2017 21
2018 13
2019 14
2020 8
2021 10
2022 10
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

742 results

Results by year

Filters applied: . Clear all
Page 1
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension.
Desai AS, Webb DJ, Taubel J, Casey S, Cheng Y, Robbie GJ, Foster D, Huang SA, Rhyee S, Sweetser MT, Bakris GL. Desai AS, et al. Among authors: webb dj. N Engl J Med. 2023 Jul 20;389(3):228-238. doi: 10.1056/NEJMoa2208391. N Engl J Med. 2023. PMID: 37467498 Clinical Trial.
Long-term adverse effects of paracetamol - a review.
McCrae JC, Morrison EE, MacIntyre IM, Dear JW, Webb DJ. McCrae JC, et al. Among authors: webb dj. Br J Clin Pharmacol. 2018 Oct;84(10):2218-2230. doi: 10.1111/bcp.13656. Epub 2018 Jul 20. Br J Clin Pharmacol. 2018. PMID: 29863746 Free PMC article. Review.
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial.
Mackenzie IS, Rogers A, Poulter NR, Williams B, Brown MJ, Webb DJ, Ford I, Rorie DA, Guthrie G, Grieve JWK, Pigazzani F, Rothwell PM, Young R, McConnachie A, Struthers AD, Lang CC, MacDonald TM; TIME Study Group. Mackenzie IS, et al. Among authors: webb dj. Lancet. 2022 Oct 22;400(10361):1417-1425. doi: 10.1016/S0140-6736(22)01786-X. Epub 2022 Oct 11. Lancet. 2022. PMID: 36240838 Free PMC article. Clinical Trial.
Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor-Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen-Targeting Small Interfering RNA.
Ranasinghe P, Addison ML, Webb DJ. Ranasinghe P, et al. Among authors: webb dj. J Am Heart Assoc. 2022 Oct 18;11(20):e027694. doi: 10.1161/JAHA.122.027694. Epub 2022 Oct 10. J Am Heart Assoc. 2022. PMID: 36216481 Free PMC article. No abstract available.
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.
Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, Ford I, Cruickshank JK, Caulfield MJ, Salsbury J, Mackenzie I, Padmanabhan S, Brown MJ; British Hypertension Society's PATHWAY Studies Group. Williams B, et al. Among authors: webb dj. Lancet. 2015 Nov 21;386(10008):2059-2068. doi: 10.1016/S0140-6736(15)00257-3. Epub 2015 Sep 20. Lancet. 2015. PMID: 26414968 Free PMC article. Clinical Trial.
Endothelium-derived endothelin-1.
Thorin E, Webb DJ. Thorin E, et al. Among authors: webb dj. Pflugers Arch. 2010 May;459(6):951-8. doi: 10.1007/s00424-009-0763-y. Epub 2009 Dec 5. Pflugers Arch. 2010. PMID: 19967386 Free PMC article. Review.
Epi-fluorescence microscopy.
Webb DJ, Brown CM. Webb DJ, et al. Methods Mol Biol. 2013;931:29-59. doi: 10.1007/978-1-62703-056-4_2. Methods Mol Biol. 2013. PMID: 23026996 Free PMC article.
742 results